AstraZeneca is suing the US regulator in a bid to prevent cheap generics of its bigselling statin Crestor rosuvastatin from hitting the market next month.The AngloSwedish company has also licensed two drugs to LEO Pharma as part of an ongoing strategy to s...
↧